141 related articles for article (PubMed ID: 11806996)
1. Missense mutations in the beta(3) subunit have a different impact on the expression and function between alpha(IIb)beta(3) and alpha(v)beta(3).
Tadokoro S; Tomiyama Y; Honda S; Kashiwagi H; Kosugi S; Shiraga M; Kiyoi T; Kurata Y; Matsuzawa Y
Blood; 2002 Feb; 99(3):931-8. PubMed ID: 11806996
[TBL] [Abstract][Full Text] [Related]
2. A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen.
Ward CM; Kestin AS; Newman PJ
Blood; 2000 Jul; 96(1):161-9. PubMed ID: 10891446
[TBL] [Abstract][Full Text] [Related]
3. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
[TBL] [Abstract][Full Text] [Related]
4. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
Coller BS; Seligsohn U; West SM; Scudder LE; Norton KJ
Blood; 1991 Nov; 78(10):2603-10. PubMed ID: 1726706
[TBL] [Abstract][Full Text] [Related]
5. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
[TBL] [Abstract][Full Text] [Related]
6. A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state.
Hauschner H; Mor-Cohen R; Seligsohn U; Rosenberg N
J Thromb Haemost; 2012 Feb; 10(2):289-97. PubMed ID: 22136613
[TBL] [Abstract][Full Text] [Related]
7. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
Kiyoi T; Tomiyama Y; Honda S; Tadokoro S; Arai M; Kashiwagi H; Kosugi S; Kato H; Kurata Y; Matsuzawa Y
Blood; 2003 May; 101(9):3485-91. PubMed ID: 12506038
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex.
Wilcox DA; Wautier JL; Pidard D; Newman PJ
J Biol Chem; 1994 Feb; 269(6):4450-7. PubMed ID: 7508443
[TBL] [Abstract][Full Text] [Related]
9. Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.
Chen YP; Djaffar I; Pidard D; Steiner B; Cieutat AM; Caen JP; Rosa JP
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10169-73. PubMed ID: 1438206
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
[TBL] [Abstract][Full Text] [Related]
11. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
[TBL] [Abstract][Full Text] [Related]
12. A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation.
Rosenberg N; Landau M; Luboshitz J; Rechavi G; Seligsohn U
J Thromb Haemost; 2004 Jul; 2(7):1167-75. PubMed ID: 15219201
[TBL] [Abstract][Full Text] [Related]
13. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes.
Sun QH; Liu CY; Wang R; Paddock C; Newman PJ
Blood; 2002 Sep; 100(6):2094-101. PubMed ID: 12200372
[TBL] [Abstract][Full Text] [Related]
15. A Ser162-->Leu mutation within glycoprotein (GP) IIIa (integrin beta3) results in an unstable alphaIIbbeta3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia.
Jackson DE; White MM; Jennings LK; Newman PJ
Thromb Haemost; 1998 Jul; 80(1):42-8. PubMed ID: 9684783
[TBL] [Abstract][Full Text] [Related]
16. A three amino acid deletion in glycoprotein IIIa is responsible for type I Glanzmann's thrombasthenia: importance of residues Ile325Pro326Gly327 for beta3 integrin subunit association.
Morel-Kopp MC; Kaplan C; Proulle V; Jallu V; Melchior C; Peyruchaud O; Aurousseau MH; Kieffer N
Blood; 1997 Jul; 90(2):669-77. PubMed ID: 9226167
[TBL] [Abstract][Full Text] [Related]
17. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
18. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa.
Losonczy G; Rosenberg N; Kiss C; Kappelmayer J; Vereb G; Kerényi A; Balogh I; Muszbek L
Thromb Haemost; 2005 May; 93(5):904-9. PubMed ID: 15886807
[TBL] [Abstract][Full Text] [Related]
19. Truncation of glycoprotein (GP) IIIa (616-762) prevents complex formation with GPIIb: novel mutation in exon 11 of GPIIIa associated with thrombasthenia.
Ferrer M; Tao J; Iruín G; Sánchez-Ayuso M; González-Rodríguez J; Parrilla R; González-Manchón C
Blood; 1998 Dec; 92(12):4712-20. PubMed ID: 9845537
[TBL] [Abstract][Full Text] [Related]
20. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
